Crassula Pharmaceuticals

Crassula Pharmaceuticals is a South Florida–based pharmaceutical corporation dedicated to advancing health through science, innovation, and quality manufacturing. We develop and produce prescription (Rx) medicines, over-the-counter (OTC) products, and advanced nutraceutical formulations that enhance patient well-being and support long-term health outcomes. Our mission is to improve lives through reliable, accessible, and innovative healthcare solutions—built on integrity, quality, and scientific excellence. Since 2017, we have operated as a Contract Development and Manufacturing Organization (CDMO), providing full-cycle services—from formulation and scale-up to regulatory dossier and finished product supply—for leading pharmaceutical companies worldwide. This model has given us deep industry expertise and the agility to adapt quickly to evolving therapeutic needs. Our operations comply with WHO-GMP, ISO and US FDA standards, and our facilities hold KOSHER and HALAL certifications, ensuring every product meets the highest global benchmarks for safety and quality. Crassula’s prescription line includes advanced drug-delivery systems designed to meet and often exceed United States Pharmacopeia (USP) and British Pharmacopeia (BP) specifications. Our nutraceutical division specializes in softgel and PQNS-enhanced (QuanticSphere™) formats—offering superior bioavailability and stability across key therapeutic areas. We are committed to continuous innovation, supporting healthcare professionals with trusted, science-driven solutions that elevate standards of care and deliver measurable impact in patient health.